Evidence map›Paper›PMID 18596923›Full record

ArticleThe Journal of clinical investigation2008

The cholinesterase-like domain of thyroglobulin functions as an intramolecular chaperone.

Jaemin Lee, Bruno Di Jeso, Peter Arvan

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Structural features of thyroglobulin linked to protein trafficking.Protein science : a publication of the Protein Society · 2023
    Article
  9. Article
  10. Defective Thyroglobulin: Cell Biology of Disease.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. The role of thyroglobulin in thyroid hormonogenesis.Nature reviews. Endocrinology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Jaemin LeeDivision of Metabolism, Endocrinology and Diabetes and Program of Cellular and Molecular Biology, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0678, USA.
Bruno Di Jeso
Peter Arvan
Diabetes Australia · AUUniversity of Salento · IT

Funding

THYROCYTE PROTEIN TRANSPORT TO THE CELL SURFACER01DK040344 · NIDDK · YESHIVA UNIVERSITY · PI ARVAN, PETER · 1993 to 2018
$7.3M
POLARIZED SECRETORY TARGETING IN CULTURED THYROCYTESR29DK040344 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ARVAN, PETER · 1988 to 1992
–
NIDDK NIH HHS DK40344NIDDK NIH HHS R01 DK040344
6 · The paper itself

Abstract

Thyroid hormonogenesis requires secretion of thyroglobulin, a protein comprising Cys-rich regions I, II, and III (referred to collectively as region I-II-III) followed by a cholinesterase-like (ChEL) domain. Secretion of mature thyroglobulin requires extensive folding and glycosylation in the ER. Multiple reports have linked mutations in the ChEL domain to congenital hypothyroidism in humans and rodents; these mutations block thyroglobulin from exiting the ER and induce ER stress. We report that, in a cell-based system, mutations in the ChEL domain impaired folding of thyroglobulin region I-II-III. Truncated thyroglobulin devoid of the ChEL domain was incompetent for cellular export; however, a recombinant ChEL protein ("secretory ChEL") was secreted efficiently. Coexpression of secretory ChEL with truncated thyroglobulin increased intracellular folding, promoted oxidative maturation, and facilitated secretion of region I-II-III, indicating that the ChEL domain may function as an intramolecular chaperone. Additionally, we found that the I-II-III peptide was cosecreted and physically associated with secretory ChEL. A functional ChEL domain engineered to be retained intracellularly triggered oxidative maturation of I-II-III but coretained I-II-III, indicating that the ChEL domain may also function as a molecular escort. These insights into the role of the ChEL domain may represent potential therapeutic targets in the treatment of congenital hypothyroidism.

Indexed as

Cell LineCholinesterasesEndoplasmic ReticulumHumansKidneyMolecular ChaperonesMutagenesis, Site-DirectedMutationOxidation-ReductionProtein FoldingProtein Structure, TertiaryRecombinant ProteinsThyroglobulinTransfectionCholinesterasesMolecular ChaperonesRecombinant ProteinsThyroglobulin

Identifiers

PMID18596923
PMCPMC2441857
OpenAlexW2097789207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.